Fetal death as a result of placental immune reconstitution inflammatory syndrome

Journal of Infection

Volumn 61, Issue 2, 2010, Pages 185-188

  Caby, F ^a,b   Lemercier, D ^a   Coulomb, A ^c   Grigorescu, R ^c   Paris, L ^a   Touafek, F ^a   Carcelain, G ^a   Canestri, A ^a,b   Pauchard, M ^a,b   Katlama, C ^a,b   Dommergues, M ^a   Tubiana, R ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

^c SERVICE DE DERMATOLOGIE   (France)

Author keywords

Congenital toxoplasmosis; Immune reconstitution inflammatory syndrome; Opportunistic infection; Placentitis

Indexed keywords

COTRIMOXAZOLE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PROTOZOAL DNA; VIRUS RNA;

ADULT; ANTIBODY TITER; ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; FEMALE; FETUS DEATH; GENOTYPE; HEPATITIS B; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOGLOBULIN BLOOD LEVEL; POLYMERASE CHAIN REACTION; PREGNANCY; TOXOPLASMOSIS; VIRUS REACTIVATION; AMNION FLUID; BLOOD; COMPLICATION; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; ISOLATION AND PURIFICATION; PARASITOLOGY; PATHOLOGY; PLACENTA; PREGNANCY COMPLICATIONS, INFECTIOUS; TOXOPLASMA; VIROLOGY; VIRUS LOAD;

ADULT; AMNIOTIC FLUID; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DNA, PROTOZOAN; FEMALE; FETAL DEATH; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RNA, VIRAL; TOXOPLASMA; TOXOPLASMOSIS; VIRAL LOAD;

EID: 77955050891     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2010.03.026     Document Type: Article

References (25)

1. Egger M., May M., Chene G., Phillips A.N., Ledergerber B., Dabis F., et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002, 360(9327):119-129.
2. May M., Sterne J.A., Sabin C., Costagliola D., Justice A.C., Thiebaut R., et al. Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. AIDS 2007, 21(9):1185-1197.
3. Price P., Mathiot N., Krueger R., Stone S., Keane N.M., French M.A. Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy. J Clin Virol 2001, 22(3):279-287.
4. French M.A. Disorders of immune reconstitution in patients with HIV infection responding to antiretroviral therapy. Curr HIV/AIDS Rep 2007, 4(1):16-21.
5. Klotz S.A., Aziz Mohammed A., Girmai Woldemichael M., Worku Mitku M., Handrich M. Immune reconstitution inflammatory syndrome in a resource-poor setting. J Int Assoc Physicians AIDS Care (Chic Ill) 2009, 8(2):122-127.
6. Huruy K., Mulu A., Mengistu G., Shewa-Amare A., Akalu A., Kassu A., et al. Immune reconstitution inflammatory syndrome among HIV/AIDS patients during highly active antiretroviral therapy in Addis Ababa, Ethiopia. Jpn J Infect Dis 2008, 61(3):205-209.
7. Lawn S.D. Immune reconstitution disease associated with parasitic infections following initiation of antiretroviral therapy. Curr Opin Infect Dis 2007, 20(5):482-488.
8. Tsambiras P.E., Larkin J.A., Houston S.H. Case report. Toxoplasma encephalitis after initiation of HAART. AIDS Read 2001, 11(12):608-610. 615-616.
9. Romand S., Wallon M., Franck J., Thulliez P., Peyron F., Dumon H. Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. Obstet Gynecol 2001, 97(2):296-300.
10. Hohlfeld P., Daffos F., Costa J.M., Thulliez P., Forestier F., Vidaud M. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med 1994, 331(11):695-699.
11. Elliott W.G. Placental toxoplasmosis. Report of a case. Am J Clin Pathol 1970, 53(3):413-417.
12. Yavuz E., Aydin F., Seyhan A., Topuz S., Karagenc Y., Tuzlali S., et al. Granulomatous villitis formed by inflammatory cells with maternal origin: a rare manifestation type of placental toxoplasmosis. Placenta 2006, 27(6-7):780-782.
13. Piche M., Battaglione V., Monticelli I., Figuccio M., Hofman P. [Placenta toxoplasmosis in the course of AIDS. Immunohistochemical and ultrastructural study of a case]. Ann Pathol 1997, 17(5):337-339.
14. French M.A. HIV/AIDS: immune reconstitution inflammatory syndrome: a reappraisal. Clin Infect Dis 2009, 48(1):101-107.
15. Shelburne S.A., Hamill R.J. The immune reconstitution inflammatory syndrome. AIDS Rev 2003, 5(2):67-79.
16. French M.A., Price P., Stone S.F. Immune restoration disease after antiretroviral therapy. AIDS 2004, 18(12):1615-1627.
17. Marty P., Bongain A., Loiseau S., Benoit B., Chevallier A., Gillet J.Y., et al. [Lethal congenital toxoplasmosis resulting from reactivation of toxoplasmosis in a pregnant HIV-positive patient]. Presse Med 2002, 31(33):1558.
18. Marty P., Bongain A., Rahal A., Thulliez P., Wasfi D., Lambert J.C., et al. Prenatal diagnosis of severe fetal toxoplasmosis as a result of toxoplasmic reactivation in an HIV-1 seropositive woman. Prenat Diagn 1994, 14(5):414-415.
19. Bachmeyer C., Mouchnino G., Thulliez P., Blum L. Congenital toxoplasmosis from an HIV-infected woman as a result of reactivation. J Infect 2006, 52(2):e55-e57.
20. Minkoff H., Remington J.S., Holman S., Ramirez R., Goodwin S., Landesman S. Vertical transmission of toxoplasma by human immunodeficiency virus-infected women. Am J Obstet Gynecol 1997, 176(3):555-559.
21. Elbez-Rubinstein A., Ajzenberg D., Dardé M.L., Cohen R., Dumètre A., Yera H., et al. Congenital toxoplasmosis and reinfection during pregnancy: case report, strain characterization, experimental model of reinfection, and review. J Infect Dis 2009, 199(2):280-285.
22. Berrebi A., Kobuch W.E. Toxoplasmosis in pregnancy. Lancet 1994, 344(8927):950.
23. Berrebi A., Kobuch W.E., Bessieres M.H., Bloom M.C., Rolland M., Sarramon M.F., et al. Termination of pregnancy for maternal toxoplasmosis. Lancet 1994, 344(8914):36-39.
24. Shelburne S.A., Visnegarwala F., Darcourt J., Graviss E.A., Giordano T.P., White A.C., et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 2005, 19(4):399-406.
25. Jasseron C., Mandelbrot L., Tubiana R., Teglas J.P., Faye A., Dollfus C., et al. Prevention of mother-to-child HIV transmission: similar access for sub-Sahara African immigrants and for French women?. AIDS 2008, 22(12):1503-1511.